Pharmaceutical Investing

Avenue Therapeutics Doses First Patient in Phase 3 Safety Trial

Pharmaceutical Investing

Cascadian Therapeutics Gets Pediatric Investigation Plan Waiver for Lead Candidate

Pharmaceutical Investing

Nuvo Pharmaceuticals Acquires Global Rights for Head Lice Treatment

Pharmaceutical Investing

DelMar Pharmaceuticals Announces Fast Track Designation for VAL-083 in Recurrent Glioblastoma

Pharmaceutical Investing

Pharmaceutical Outlook 2018: M&A Deals Could Increase Drug Development

Pharmaceutical Investing

Corbus Pharmaceuticals Kicks Off Phase 2 Study

Pharmaceutical Investing

Pharma Trends 2017: FDA Pushes Creation of More Generic Drugs

Pharmaceutical Investing

IntelGenx Obtains Amended Drug Establishment License

Pharmaceutical Investing

Isodiol International Inc. Announces Binding Agreement to Acquire Biosynthesis Pharma Group

Cannabis Investing News

Medicure Obtains Exclusive License for Cardiovascular Drug

Pharmaceutical Investing

Nuvo Signs Licensing Agreement with Gebro Pharma

Pharmaceutical Investing

Corbus Kicks Off Phase 3 Study RESOLVE-1

Pharmaceutical Investing

Latest pharmaceutical News

More pharmaceutical News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES